Aurora Spine Announces First Surgery Using TiNano(TM) Interbody Cage

Aurora Spine Corporation (TSX VENTURE:ASG) announced today the first surgery
using the Discovery(TM) interbody cage with TiNano(TM) plasma spray coating. The
surgery, a multi-level case, was performed at Tri-City Medical Center in
Oceanside, CA by Dr. Neville Alleyne.


"The new TiNano titanium spray blast coating has increased the surface area for
superior osteointegration. TiNano is the next generation of interbody fusion
cages" said Dr. Alleyne. Dr. Alleyne is a board-certified orthopedic surgeon and
the director of the Orthopaedic Spine Center at Tri-City Medical Center. He uses
minimally invasive approaches to spinal disorders. 


The Aurora Discovery cages with TiNano plasma spray coating allow for bone
ingrowth due to its porous structure. The surgery marks the introduction of the
TiNano product line, the most recent addition of advanced spinal products in the
Aurora MIS portfolio. Aurora Spine continues to expand its product offerings in
support of its mission of minimally invasive technology.


About Aurora Spine 

Aurora Spine is an early stage company focused on bringing new solutions to the
spinal implant market through a series of innovative, minimally invasive,
regenerative spinal implant technologies.


Forward-Looking Statements 

This news release contains forward-looking information that involves substantial
known and unknown risks and uncertainties, most of which are beyond the control
of Aurora Spine, including, without limitation, those listed under "Risk
Factors" and "Cautionary Statement Regarding Forward-Looking Information" in
Aurora Spine's final prospectus (collectively, "forward-looking information").
Forward-looking information in this news release includes information concerning
the proposed use and success of Aurora Spine's products in surgical procedures.
Aurora Spine cautions investors of its securities about important factors that
could cause Aurora Spine's actual results to differ materially from those
projected in any forward-looking statements included in this news release. Any
statements that express, or involve discussions as to, expectations, beliefs,
plans, objectives, assumptions or future events or performance are not
historical facts and may be forward-looking and may involve estimates,
assumptions and uncertainties which could cause actual results or outcomes to
differ unilaterally from those expressed in such forward-looking statements. No
assurance can be given that the expectations set out herein will prove to be
correct and, accordingly, prospective investors should not place undue reliance
on these forward looking statements. These statements speak only as of the date
of this press release and Aurora Spine does not assume any obligation to update
or revise them to reflect new events or circumstances.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
[phone]


Eric Fronk
Chief Financial Officer
[phone]